BROERSEN, Ladislaus Maria,HAGEMAN, Robert Johan Joseph,LANSBERGEN, Marieke,GROENENDIJK, Martine,DE WILDE, Mattheus Cornelis
申请号：
SG11201707953P
公开号：
SG11201707953PA
申请日:
2015.02.02
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
The invention pertains to the use of (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof, and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6 DHA), eicosapentaenoic acid (20:5 EPA) and docosapentaenoic acid (22:5 DPA), or esters thereof in the manufacture of a composition for use in a method for treating, stabilizing or slowing down brain glucose metabolism deficit in a subject in need thereof.
